Oral PCSK9 Inhibitor Enlicitide Reduces LDL Cholesterol by Approximately 60% in Phase 3 Trial
📰 Original title: New pill cuts “bad” cholesterol by 60% in major trial
🤖 IA: It's clickbait ⚠️
👥 Usuarios: It's clickbait ⚠️
View full AI summary: https://killbait.com/en/oral-pcsk9-inhibitor-enlicitide-reduces-ldl-cholesterol-by-approximately-60-in-phase-3-trial/?redirpost=cee93522-b80d-43fc-aa95-396287d3e6e5

A phase 3 clinical trial published in The New England Journal of Medicine demonstrated that enlicitide, an experimental oral PCSK9 inhibitor developed by Merck, significantly lowered low-density…
Here's the third (and last!) entry in a series of blog posts on the #cdisc Dataset-JSON standard. This entry goes over the REST API component and potential issues with it.
Pushing for the future of #clinicaltrial #data (and related to the #pharmaverse and #rstats folks in #biomedicalresearch) and better workflows for running those trials.
https://brianrepko.github.io/blog/posts/2026-03-11-datasetjson-part3/
Clinical Trial Finds Sulthiame Reduces Breathing Pauses in Sleep Apnea Patients
📰 Original title: Scientists may have found a pill for sleep apnea
🤖 IA: It's not clickbait ✅
👥 Usuarios: It's not clickbait ✅
View full AI summary: https://killbait.com/en/clinical-trial-finds-sulthiame-reduces-breathing-pauses-in-sleep-apnea-patients/?redirpost=94d36cd5-c000-419c-8960-d5714a103dbd